Celecoxib (Compound)

Synonyms:celecoxib, 169590-42-5, Celebrex, Celebra, Onsenal, Celocoxib, Celecox, SC 58635, 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE, SC-58635, YM177, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide, 184007-95-2, YM 177, C17H14F3N3O2S, HSDB 7038, UNII-JCX84Q7J1L, p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide, MFCD00941298, SC58635, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide, 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, YM-177, CHEMBL118, JCX84Q7J1L, CHEBI:41423, 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, 194044-54-7, NCGC00091455-01, Xilebao, DSSTox_CID_2777, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide, benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-, DSSTox_RID_76725, DSSTox_GSID_22777, Solexa, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de, Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-, Celebrex (TN), SMR000550473, CAS-169590-42-5, SR-01000837528, Celecoxibum, Celecoxib [USAN:INN:BAN], CCRIS 9330, TPI-336, Celecoxib- Bio-X, Celecoxib-[d4], Onsenal (TN), AI-525, CEP-33222, CELEBCOXIB, Spectrum_000432, 1oq5, Spectrum2_001576, Spectrum3_001996, Spectrum4_000182, Spectrum5_001324, cid_2662, SCHEMBL3708, Celecoxib (JAN/USP/INN), DFN15, BSPBio_003596, KBioGR_000723, KBioGR_002351, KBioSS_000912, KBioSS_002354, MLS001165684, MLS001195656, MLS001304708, MLS006011862, BIDD:GT0408, DivK1c_000893, SPECTRUM1503678, SPBio_001512, DFN-15, GTPL2892, Celecoxib, >=98% (HPLC), DTXSID0022777, BDBM11639, HMS502M15, KBio1_000893, KBio2_000912, KBio2_002351, KBio2_003480, KBio2_004919, KBio2_006048, KBio2_007487, KBio3_002830, KBio3_003037, EX-A175, SYN3015, cMAP_000027, NINDS_000893, BCPP000290, Elyxyb (DFN-15; oral solution), HMS1922G14, HMS2089L18, HMS2093I07, HMS2234N18

Pubchem:PUBCHEM:2662

Id:2662

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Celecoxib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Celecoxib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Celecoxib.

Results found

Linked to

	Label	Description
	BRD-K02637541-001-06-5 Substance (Entity type)	A Substance
	DCSTRUCT ID 00568 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00568; PubChem_CID:2662, FILE=drugcentral_drug_00568.json)
	celecoxib (9b2392ea-8a03-42bc-92c6-3c506525f39b) Collection (Entity type)	Metadatata for celecoxib
	Celecoxib negatively regulates GDF15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Celecoxib positively regulates S100A9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Celecoxib in similarity relationship with dexamethasone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Celecoxib negatively regulates IER3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Celecoxib bioactivity Carbonic anhydrase 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Celecoxib negatively regulates OLFM4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Celecoxib negatively regulates CXCL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS